Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Coulter Moving Headquarters; Cutting Jobs at Palo Alto Facility

NEW YORK (GenomeWeb News) – Beckman Coulter will move its existing headquarters from Fullerton, Calif., to the nearby city of Brea by the end of 2009. The firm also is cutting 158 jobs from its Palo Alto, Calif., operations, according to a notice posted last week on the website of the state’s Employment Development Department.
 
Mary Luthy, a Beckman Coulter spokesperson, told GenomeWeb Daily News today that the firm is in the process of consolidating its Orange County, Calif., operations into its space in Brea, and that the firm would cease to have a presence in Fullerton once the relocation is completed.
 
The consolidation is part of a plan devised last year to identify areas where the firm could cut costs. Luthy said Beckman identified 100,000 square feet of wasted space in its facilities and expects it will identify even more excess space as it continues to evaluate its operations. The firm also plans to consolidate some of its West Coast warehouses into one center in Chino, Calif.
 
“At this time there are no planned layoffs,” associated with the relocation to Brea, said Luthy. “We have said that there may be some outsourcing or relocations.”
 
Luthy said that the reduction in staff in Palo Alto is part of Beckman’s plan to close its facilities there and move its centrifuge manufacturing operations to Indianapolis, which the firm announced a year ago.
 
She said that the job cuts would happen between now and September, as pieces of the manufacturing processes are relocated. The 158 staffers include those who decided against relocating and those who were not offered a position in Indianapolis, she said.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.